Sign in

CIK 0001806310 · Non-accelerated filer<br>Smaller reporting company

Taysha Gene Therapies, Inc.

Sign in to watch
Ticker
TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
843199512
Phone
(214) 612-0000
Business address
3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. SCHEDULE 13D/A Stake Beneficial Ownership Report
  8. 4 Insider Changes in Ownership
  9. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  10. 8-K Event Material agreement · Other events
  11. 424B5 Offering Prospectus
  12. 8-K/A Event Regulation FD disclosure · Other events
  13. 424B5 Offering Prospectus
  14. 8-K Event Regulation FD disclosure · Other events
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. DEFR14A Other DEFR14A
  19. ARS Other Annual Report to Security Holders
  20. DEFA14A Proxy Proxy Materials

Page 5 of 21 · 403 filings